glutathione platinum resistance increase drugs A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in Unlike traditional collagen supplements Platinum-resistant ovarian cancer: mapping mechanisms
Platinum resistant ovarian cancer: mapping mechanisms and emerging therapeutic strategies EurekAlert! Ovarian CancerInsights into Platinum Resistance and Overcoming It A platinum(IV) prodrug strategy to overcome glutathione based oxaliplatin resistance Communications Chemistry Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation Cell Death & Disease
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


